{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:06:35Z","timestamp":1790935595018,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":5398,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1038\/modpathol.3801016","type":"journal-article","created":{"date-parts":[[2008,1,18]],"date-time":"2008-01-18T10:34:46Z","timestamp":1200652486000},"page":"431-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["IMP-3 is a novel progression marker in malignant melanoma"],"prefix":"10.1016","volume":"21","author":[{"given":"Jennifer G","family":"Pryor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A","family":"Bourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy O","family":"Spaulding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glynis A","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haodong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.3801016_bib1","first-page":"1852","article-title":"Three patients with a Spitz naevus that later turned out to be a melanoma","volume":"149","author":"Bron","year":"2005","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1038\/modpathol.3801016_bib2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5858\/2006-130-617-MAOEIP","article-title":"Medicolegal aspects of error in pathology","volume":"130","author":"Troxel","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.3801016_bib3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1067\/mjd.2001.111635","article-title":"MIB-1 monoclonal antibody to determine proliferative activity of Ki-67 antigen as an adjunct to the histopathologic differential diagnosis of Spitz nevi","volume":"44","author":"Bergman","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/modpathol.3801016_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/CMR.0b013e328042bb36","article-title":"Diagnosis and treatment of cutaneous melanoma: state of the art 2006","volume":"17","author":"Garbe","year":"2007","journal-title":"Melanoma Res"},{"key":"10.1038\/modpathol.3801016_bib5","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","article-title":"Model predicting survival in stage I melanoma based on tumor progression","volume":"81","author":"Clark","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.3801016_bib6","doi-asserted-by":"crossref","first-page":"342S","DOI":"10.1038\/jid.1993.60","article-title":"Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent","volume":"100","author":"Guerry","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1038\/modpathol.3801016_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1590\/S0100-879X2003000300009","article-title":"Vertical growth phase and positive sentinel node in thin melanoma","volume":"36","author":"Oliveira Filho","year":"2003","journal-title":"Braz J Med Biol Res"},{"key":"10.1038\/modpathol.3801016_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s10434-000-0262-z","article-title":"Incidence of sentinel node metastasis in patients with thin primary melanoma (< or =1 mm) with vertical growth phase","volume":"7","author":"Bedrosian","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/modpathol.3801016_bib9","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1346-8138.2007.00323.x","article-title":"Sentinel lymph node biopsy in patients with thin melanomas","volume":"34","author":"Cecchi","year":"2007","journal-title":"J Dermatol"},{"key":"10.1038\/modpathol.3801016_bib10","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.3801016_bib11","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.bjps.2006.11.001","article-title":"A prospective analysis of c-myc oncoprotein levels as a prognostic marker in malignant melanoma","volume":"60","author":"Ramsden","year":"2007","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1038\/modpathol.3801016_bib12","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1200\/JCO.2006.08.1463","article-title":"Identification of high-risk patients among those diagnosed with thin cutaneous melanomas","volume":"25","author":"Gimotty","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.3801016_bib13","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1128\/MCB.19.2.1262","article-title":"A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development","volume":"19","author":"Nielsen","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1038\/modpathol.3801016_bib14","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1038\/sj.onc.1201110","article-title":"Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein","volume":"14","author":"M\u00fceller-Pillasch","year":"1997","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.3801016_bib15","doi-asserted-by":"crossref","first-page":"18517","DOI":"10.1074\/jbc.M500270200","article-title":"The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells","volume":"280","author":"Liao","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.3801016_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/rep.1.00664","article-title":"Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer","volume":"130","author":"Hammer","year":"2005","journal-title":"Reproduction"},{"key":"10.1038\/modpathol.3801016_bib17","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.humpath.2007.02.001","article-title":"Extrapulmonary small cell carcinomas express K homology domain containing protein overexpressed in cancer, but carcinoid tumors do not","volume":"38","author":"Simon","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.3801016_bib18","first-page":"671","article-title":"Increased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer","volume":"24","author":"Gu","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1038\/modpathol.3801016_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/01.pas.0000149688.98333.54","article-title":"KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas","volume":"29","author":"Yantiss","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.3801016_bib20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.humpath.2006.11.011","article-title":"High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not","volume":"38","author":"Xu","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.3801016_bib21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/sj.bjc.6600806","article-title":"L523S, an RNA-binding protein as a potential therapeutic target for lung cancer","volume":"88","author":"Wang","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.3801016_bib22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1470-2045(06)70732-X","article-title":"Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study","volume":"7","author":"Jiang","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1038\/modpathol.3801016_bib23","series-title":"AJCC Cancer Staging Manual","author":"Greene","year":"2002"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/3801016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3801016","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222041473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222041473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3801016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:17:47Z","timestamp":1760231867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222041473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0893395222041473"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.3801016","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IMP-3 is a novel progression marker in malignant melanoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.3801016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}